QUIDELORTHO CORP Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid
QUIDELORTHO CORP (QDEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid of $12.20 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Additional Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid · last filed 2026-02-19
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, share-based liabilities paid for the quarter ending 2023-12-31 was $3.40M, a 3.03% increase year-over-year.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, share-based liabilities paid for the quarter ending 2023-10-01 was $3.00M, a 0.00% change year-over-year.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, share-based liabilities paid for the quarter ending 2023-07-02 was $2.80M, a 74.31% decline year-over-year.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, share-based liabilities paid for the quarter ending 2023-04-02 was $3.00M.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, share-based liabilities paid for fiscal 2023 was $12.20M, a 29.07% decline from fiscal 2023.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, share-based liabilities paid for fiscal 2023 was $17.20M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid 12 month |
|---|---|---|---|---|
| 2023-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $6.40M derived: sum of 2 quarters · filed 2026-02-19 | $9.20M derived: sum of 3 quarters · filed 2026-02-19 | $12.20M 10-K · filed 2026-02-19 |
| 2023-10-01 | $3.00M 10-Q · filed 2024-11-08 | $5.80M derived: sum of 2 quarters · filed 2024-11-08 | $8.80M 10-Q · filed 2024-11-08 | $12.10M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | $2.80M 10-Q · filed 2024-08-01 | $5.80M 10-Q · filed 2024-08-01 | $9.10M derived: sum of 3 quarters · filed 2025-02-27 | $12.10M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $3.00M 10-Q · filed 2024-05-09 | $6.30M derived: sum of 2 quarters · filed 2025-02-27 | $9.30M derived: sum of 3 quarters · filed 2025-02-27 | $20.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.30M derived: sum of 2 quarters · filed 2025-02-27 | $17.20M derived: sum of 3 quarters · filed 2025-02-27 | $17.20M 10-K · filed 2025-02-27 |
| 2022-10-02 | $3.00M 10-Q · filed 2023-11-02 | $13.90M derived: sum of 2 quarters · filed 2023-11-02 | $13.90M 10-Q · filed 2023-11-02 | |
| 2022-07-03 | $10.90M 10-Q · filed 2023-08-09 | $10.90M 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |